ADM is undertaking significant changes to its soy protein production network, aimed at improving operational efficiency and better serving its global customer base.

The company has announced that it will cease operations at its Bushnell, Illinois facility while leveraging the recently recommissioned soy protein plant in Decatur, Illinois, along with other facilities in its extensive global network.

As part of ADM’s broader strategy to optimise its portfolio, this decision reflects a commitment to consolidating production capabilities and enhancing service levels.

Back in April, ADM announced that it would permanently shutter its soybean processing facility in Kershaw, South Carolina, as part of a broader strategy to streamline operations and reduce costs, according to Reuters.

Ian Pinner, president of ADM’s Nutrition business, highlighted the importance of these changes in reinforcing the company’s competitive position within the industry.

“Optimising our soy protein production network is an example of how we’re strengthening our asset platform, combining capital discipline with smart organic innovation and operational improvements to increase cash flows and returns,” said Pinner.

The decision to close the Bushnell facility is part of ADM's strategy to focus on its most efficient operations, allowing for a more streamlined approach to meet the growing global demand for soy protein products.

The Decatur plant, which has resumed operations, is expected to play a crucial role in this transition, providing enhanced manufacturing efficiencies and supporting ADM's speciality ingredients business.

The company says it is committed to ensuring a smooth transition for affected customers and employees during this operational shift.

Pinner reassured stakeholders, stating: “We are prioritising treating any affected colleagues with respect as we advance this process,” indicating that the company is focused on minimising disruption.

This move comes at a time when the demand for plant-based proteins is on the rise, driven by consumer trends toward healthier diets and sustainable food sources.

Bunge Global also recently has acquired IFF's soy and lecithin business, a move that aimed to enhance Bunge's product portfolio and strengthen its position in the F&B sector.

J Erik Fyrwald, CEO of IFF, highlighted during a conference call that the divested products were better suited for Bunge's operational expertise.

“They’re highly commoditised and managed far more efficiently by Bunge than they were by us,” said Fyrwald. He noted that these products delivered only low single-digit EBITDA margins for IFF, and selling them will enable the company to focus on its more specialised isolated soy protein business – boosting both margins and innovation potential.